It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2009.
2009 | Hyderabad, Telangana, India | ActiveDbs Pharma Private Limited, a active private limited company, was established on 16 November 2009 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232TG2009PTC065842. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹0.20 M.
It upholds a compliant status. Its leadership includes Dumpala Venkata Satyanarayana (Director), Kumara Swamy Bairi (Director), Gadireddy Ramesh (Director). Past directors included Chandana Thota, Suresh Babu Damisetty Bala, Chandana Damisetty. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at #6, Palm County, Near H.S Darga Shaikpet, Hyderabad, Telangana, 500008.
U24232TG2009PTC065842
065842
16 November 2009
₹2.00 M
₹0.20 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Dbs Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dumpala Venkata Satyanarayana | Director | 15 Jul 2010 | Current |
| Kumara Swamy Bairi | Director | 15 Mar 2025 | Current |
| Gadireddy Ramesh | Director | 06 Jun 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Apr 2013 | Past |
| Pramod Abcsdd | Director | 06 Jun 2019 | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dbs Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 41.76% increase. The company also saw a substantial improvement in profitability, with a 152.83% increase in profit. The company's net worth Soared by an impressive increase of 64.67%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Dbs Pharma had a promoter holding of 28.05% and a public holding of 71.95%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Dbs Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dbs Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dbs Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kumara Swamy Bairi was appointed as a Director was appointed as a Director on 15 Mar 2025 & has been associated with this company since 9 months 28 days . was documented.
Progress on Dbs Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Dbs Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
Progress on Gadireddy Ramesh was appointed as a Director was appointed as a Director on 06 Jun 2019 & has been associated with this company since 6 years 7 months . was documented.
Dumpala Venkata Satyanarayana was appointed as a Director was appointed as a Director on 15 Jul 2010 & has been associated with this company since 15 years 5 months . was recorded as a recent event.
Progress on Dbs Pharma Private Limited was registered on 16 Nov 2009 with Roc Hyderabad & aged 16 years 1 month as per MCA records. was documented.
The CIN of Dbs Pharma Private Limited is U24232TG2009PTC065842.
Dbs Pharma Private Limited is headquartered at #6, Palm County, Near H.S Darga Shaikpet, Hyderabad, Telangana, 500008.
Dbs Pharma Private Limited was incorporated on 16 November 2009.
The current directors of Dbs Pharma Private Limited are
The primary industry of Dbs Pharma Private Limited is Trade.
Dbs Pharma Private Limited is unlisted.
The authorized capital of Dbs Pharma Private Limited is ₹2.00 M, and the paid-up capital is ₹0.20 M.
The compliance status of Dbs Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX